Moderna stock more than doubles after melanoma vaccine trial shows
Drugmaker Moderna's stock more than doubled on Wednesday morning after the company announced a successful experimental mRNA vaccine to treat...
Read moreDrugmaker Moderna's stock more than doubled on Wednesday morning after the company announced a successful experimental mRNA vaccine to treat...
Read more
